BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• 7 Health Ventures Invests in Tulip Medical

  September 15, 2008

   · 

  1 min read
• Drug Development

  Targeted Use of OSI Pharmaceuticals, Inc.'s Tarceva Effective for Some Tumors

  September 15, 2008

   · 

  1 min read
• Deals

  Icahn Raises Stake in Amylin Pharmaceuticals, Inc. to 7.3 Percent

  September 15, 2008

   · 

  1 min read
• FDA

  Merck & Co., Inc. Vaccine Wins OK for Vaginal Cancer

  September 15, 2008

   · 

  1 min read
• Drug Development

  Genta Incorporated Announces Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma

  September 15, 2008

   · 

  5 min read
• FDA

  ProStrakan Group Announces FDA Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy

  September 15, 2008

   · 

  5 min read
• Drug Development

  Othera Pharmaceuticals Initiates Phase I/II Clinical Trial of OT-730 In Ocular Hypertension and Glaucoma

  September 15, 2008

   · 

  1 min read
• Drug Development

  Synta Pharmaceuticals Release: Elesclomol Two-Year Survival and Integrated Safety Data Presented at the 33rd Congress of the European Society for Medical Oncology

  September 15, 2008

   · 

  1 min read
• FDA

  Masimo Corporation Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors; Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin Adhesive Sensors

  September 15, 2008

   · 

  5 min read
• Deals

  Sanofi-Aventis (France) Extends Offer for Czech Zentiva

  September 15, 2008

   · 

  1 min read